Literature DB >> 12975302

Somatic instability of the NF2 gene in schwannomatosis.

David L Kaufman1, Bianca S Heinrich, Christine Willett, Arie Perry, Frederick Finseth, Raymond A Sobel, Mia MacCollin.   

Abstract

CONTEXT: Schwannomatosis is a newly described form of neurofibromatosis of unclear pathogenesis. PATIENT AND METHODS: We studied the NF2 locus on chromosome 22 in 7 tumor specimens resected from a 36-year-old man with schwannomatosis of the right ulnar nerve.
RESULTS: Unrelated truncating NF2 gene mutations were detected in 4 tumor specimens. None of the NF2 mutations were present in the blood specimen. Loss of heterozygosity at the NF2 locus was seen in all tumors, and in every case the same allele was lost. Loss of distal chromosome 22 markers was variable. Fluorescence in situ hybridization results were consistent with monosomy 22 in 4 tumors and mitotic recombination or nondisjunction in 1.
CONCLUSIONS: Molecular analysis of tumor specimens distinguishes schwannomatosis from other forms of neurofibromatosis. Further work is needed to understand the natural history and molecular biology of this condition.

Entities:  

Mesh:

Year:  2003        PMID: 12975302     DOI: 10.1001/archneur.60.9.1317

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  7 in total

1.  Ophthalmological manifestations in segmental neurofibromatosis type 1.

Authors:  M Ruggieri; P Pavone; A Polizzi; M Di Pietro; A Scuderi; A Gabriele; A Spalice; P Iannetti
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

2.  Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria.

Authors:  Scott R Plotkin; Jaishri O Blakeley; D Gareth Evans; C Oliver Hanemann; Theo J M Hulsebos; Kim Hunter-Schaedle; Ganjam V Kalpana; Bruce Korf; Ludwine Messiaen; Laura Papi; Nancy Ratner; Larry S Sherman; Miriam J Smith; Anat O Stemmer-Rachamimov; Jeremie Vitte; Marco Giovannini
Journal:  Am J Med Genet A       Date:  2013-02-07       Impact factor: 2.802

3.  A case of multiple cutaneous schwannomas; schwannomatosis or neurofibromatosis type 2?

Authors:  A J Murray; T A T Hughes; J W Neal; E Howard; D G R Evans; P S Harper
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-02       Impact factor: 10.154

4.  Germline mutation of INI1/SMARCB1 in familial schwannomatosis.

Authors:  Theo J M Hulsebos; Astrid S Plomp; Ruud A Wolterman; Els C Robanus-Maandag; Frank Baas; Pieter Wesseling
Journal:  Am J Hum Genet       Date:  2007-02-16       Impact factor: 11.025

5.  Immortalized Human Schwann Cell Lines Derived From Tumors of Schwannomatosis Patients.

Authors:  Kimberly Laskie Ostrow; Katelyn Donaldson; Jaishri Blakeley; Allan Belzberg; Ahmet Hoke
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

6.  Segmental neurofibromatosis type 2: discriminating two hit from four hit in a patient presenting multiple schwannomas confined to one limb.

Authors:  Elisabeth Castellanos; Isabel Bielsa; Cristina Carrato; Imma Rosas; Ares Solanes; Cristina Hostalot; Emilio Amilibia; José Prades; Francesc Roca-Ribas; Conxi Lázaro; Ignacio Blanco; Eduard Serra
Journal:  BMC Med Genomics       Date:  2015-01-24       Impact factor: 3.063

Review 7.  The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis.

Authors:  Hildegard Kehrer-Sawatzki; Said Farschtschi; Victor-Felix Mautner; David N Cooper
Journal:  Hum Genet       Date:  2016-12-05       Impact factor: 4.132

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.